Timely Capacity Analysis to Support Commercial Launch

A mid-sized pharmaceutical company specializing in rare disease therapeutics was preparing for
its first commercial launch. With a lean clinical supply team focused on supporting multiple
studies, they hadn’t yet conducted a comprehensive, end-to-end commercial supply planning
exercise.

‍
When a new VP of TechOps came on board, he immediately raised critical questions:

‍
- Do we have sufficient capacity to support future sales?
- What are our working capital requirements?
- What is the optimal safety stock level to avoid both stock-outs and overstock?

‍
Recognizing the need for a more sophisticated approach, the team implemented The Master
Planner — a vertical, pharma-specific supply planning solution from ABC-Plan.

‍
Thanks to its built-in Capacity Analysis, time-phased planning parameters, and powerful
Optimization Engine, the team was able to quickly assess their drug substance needs. The
Analytics Add-On went even further, providing insights that answered the VP’s questions —
and uncovered a critical gap: they would require a second drug substance CMO by year two
post-launch.

‍
This insight led to an immediate initiative to identify and qualify an additional manufacturing
partner — months ahead of schedule.

‍
Unlike generic ERP planning tools, The Master Planner is built specifically for pharma and
biotech. There’s no lengthy or costly customization process. We deployed it in one day, and the
client team was up and running by the end of the first week — accelerating their readiness by six
months and saving significant resources.

‍
“Your solution makes me and my entire team look good.”
— Director of Supply Chain

‍
✨ Curious how this could work for your team? Let’s connect.

‍